Skip to main content
. 2015 Oct 22;10(10):e0140823. doi: 10.1371/journal.pone.0140823

Fig 1. Effects of BHD on neurological deficits and brain function in mice after cerebral ischemic/reperfusion (CIR) injury.

Fig 1

(A) Typical animal-tracking profiles within 3 min for the evaluation of neurological deficits. (B) Representative micro-PET analysis of brain function (glucose metabolism) in live mice at 24 h after stroke. Animal groups include sham, vehicle-treated animals (ischemic stroke, CIR), BHD-treated animals (CIR+BHD; 1.0 g/kg, p.o., twice daily), and TPA-treated animals (CIR+TPA; 10 mg/kg, i.v. at day one), with treatment administered 2 h after ischemic stroke. The experiment was repeated at least 3–5 times, with similar results. #p < 0.05 compared with the sham group; *p < 0.05 compared with the CIR group.